ADAPT and Improvise: Overcoming Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer

Eur Urol. 2023 Jun;83(6):495-496. doi: 10.1016/j.eururo.2023.02.018. Epub 2023 Mar 9.

Authors

Priyamvada Maitre¹, Vijay Sangar², Ananya Choudhury³

Affiliations

¹ Department of Clinical Oncology, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK.
² Department of Uro-Oncology, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK.
³ Department of Clinical Oncology, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK. Electronic address: ananya.choudhury@nhs.net.

PMID: 36898871
DOI: 10.1016/j.eururo.2023.02.018

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Adjuvants, Immunologic / therapeutic use
Administration, Intravesical
BCG Vaccine / therapeutic use
Humans
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms* / drug therapy

Substances

BCG Vaccine
Adjuvants, Immunologic

Grants and funding

DH_/Department of Health/United Kingdom